MedTrace Logo

Home Telemonitoring in Patients at High Risk for Readmission

NCT02136186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1380

Last updated 2020-11-10

No results posted yet for this study

Summary

This study will evaluate the efficacy of home telemonitoring as an intervention to decrease hospital readmissions in patients at high risk for readmission. The overall readmission rate for high-risk MCF hospital patients is approximately 20%. Currently a system is in place to identify and score all MCF patients for their risk of readmission. This score is based on multiple variables including but not limited to: co-morbid conditions, patient's health literacy, whether they are a Medicare/Medicaid patient, their in-home social support, and whether they have had prior hospital admissions within the previous year. The literature shows that home telemonitoring of patients has had mixed results for effectiveness at preventing hospitalizations and emergency department visits. Many of these reports have restricted studies to patients with specific diseases or general characteristics; some have shown improved results while others have not. No study has examined patients who are high risk for readmission to determine if home telemonitoring for 30 days post-discharge reduces the risk for 30-day readmission.

Conditions

  • Inpatients

Interventions

DEVICE

Philips Telehealth

patients will be provided with a philips home telemonitoring system post hospital discharge

Sponsors & Collaborators

  • Brooks Health System

    collaborator UNKNOWN

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Nancy Dawson, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02136186 on ClinicalTrials.gov